Some Common Dose–Exposure–Response Estimands and Conditions for Their Causal Identifiabilitycpt: pharmacometrics & systems pharmacologyIF02026-01-290OAAI
Comprehensive Safety Exposure-Response Analysis to Support Ritlecitinib Dose Selection综合安全性暴露-反应分析以支持Ritlecitinib剂量选择CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32025-05-120OA
Operating Characteristics of the Simulated Healthy Participant Approach in Impaired Clearance StudiesAAPS JOURNALIF3.72025-01-220PRE
Population exposure-response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areataCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32025-01-150OA
Implementing a Bayesian approach using Stan with Torsten: Population pharmacokinetics analysis of somatrogonCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32024-12-090OAAI
Automated Poisson regression exposure-response analysis for binary outcomes with PoissonERMCPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYIF32024-07-310OA
Simulating Healthy Participant Pharmacokinetics for Renal and Hepatic Impairment Studies: Retrospective Assessment of the ApproachAAPS JOURNALIF3.72024-06-062OA
Volatile-compound fingerprinting and discrimination of positional isomers in stamp-pad ink tracing using HS-GC-IMS combined with multivariate statistical analysisANALYTICAL AND BIOANALYTICAL CHEMISTRYIF3.82024-01-084PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向